Statistics

Total Visits

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial52

Select a period of time:

Number of views in the range

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial13

Views

Views
September 20257
October 20252
November 20251
December 20250
January 20260
February 20260
March 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Brazil3
Chile1
Colombia1
Venezuela1
 

Top cities views

Views
Dallas6
Arauca1
Curitiba1
Guarulhos1
Ipatinga1
Santiago1